Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financi... ((unaudited) (1 A...)

Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financial Results

Date:11/6/2008

(unaudited) (1)

ASSETS

Current assets:

Cash and cash equivalents $63,713 $76,293

Short-term investments 280,803 406,060

Accounts receivable, net of allowance 8,515 21,637

Inventory 9,861 12,187

Assets held for sale 42,975 -

Other current assets 4,420 7,106

Total current assets 410,287 523,283

Property and equipment, net 73,641 114,420

Goodwill 78,431 78,431

Other intangible assets, net 1,971 2,680

Other assets 4,022 6,289

Total assets $568,352 $725,103

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $2,113 $3,589

Accrued compensation 14,723 14,680

Accrued expenses to contract manufacturers - 40,444

Accrued expenses 15,715 12,446

Interest payable 85 2,638

Capital lease obligations, current portion 1,401 2,335

Deferred revenue, current portion 11,970 19,620

Other current liabilities 2,515 2,340

Total current liabilities 48,522 98,092

Convertible subordinated notes 315,000 315,000

Capital lease obligations
'/>"/>

Post Your Comments:

Nektar Therapeutics Repurchases $100 Million of Convertible Debt and Reports Third Quarter 2008 Financi...((unaudited) (1 A...),Health